Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G10 | O15496 | 2/20 | 0.52 |
| ▸ | GCGR | P47871 | 8/20 | 0.51 |
| ▸ | GIPR | P48546 | 1/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | MAT2A | P31153 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ECE1 | P42892 | 1/20 | 0.41 |
| ▸ | CCR9 | P51686 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2643230 | 0.86 | GCGR (0.55) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL721418 | 0.84 | GCGR (0.57) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL2643861 | 0.82 | GCGR (0.56) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL2643736 | 0.82 | GCGR (0.51) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL2643458 | 0.79 | GCGR (0.54) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL2643993 | 0.76 | GCGR (0.52) | PLA2G10GCGRGIPRKCNH2MAT2A | |
| SCHEMBL2642977 | 0.71 | GCGR (0.80) | GCGRGIPRKCNH2 | |
| SCHEMBL3570450 | 0.69 | PLA2G10 (0.79) | PLA2G10PPARGNOTUMPLA2G2APLA2G5 | |
| SCHEMBL3198946 | 0.69 | CCR2 (0.71) | PPARGCCR9 | |
| SCHEMBL27346889 | 0.69 | PLA2G10 (1.00) | PLA2G10PPARGNOTUMPLA2G2APLA2G5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7598398-B2 | Acyl indoles, compositions containing such compounds and methods of use | MERCK & CO., INC. (US) | 2009-10-06 | — | — | US | disclosed |
| US-20070088071-A1 | Acyl indoles, compositions containing such compounds and methods of use | MERCK SHARP & DOHME LLC | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088071-A1 | Acyl indoles, compositions containing such compounds and methods of use | GPR119, IAPP, GLP1R | PLA2G10 909/4885GCGR 6/4885GIPR 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.